help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 27, 2005
Molecular Endocrinology, doi:10.1210/me.2004-0350
A more recent version of this article appeared on May 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
19/5/1373    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masur, K.
Right arrow Articles by Beinborn, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masur, K.
Right arrow Articles by Beinborn, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Hazardous Substances DB
*GLUCAGON

Submitted on September 3, 2004
Accepted on January 18, 2005

Basal Receptor Activation by Locally Produced Glucagon-like Peptide-1 Contributes to Maintaining Beta Cell Function

Kai Masur, Elmi C. Tibaduiza, Ci Chen, Brooke Ligon, and Martin Beinborn*

Molecular Pharmacology Research Center, Molecular Cardiology Research Institute, Tufts-New England Medical Center, Boston, MA; Department of Neuroscience, Tufts University, Boston, MA

* To whom correspondence should be addressed. E-mail: MBeinborn{at}Tufts-NEMC.org.

Glucagon-like peptide 1 (GLP-1) is a physiological stimulus of pancreatic beta cell function. This enteroendocrine hormone is produced by intestinal L-cells, and is delivered via the blood stream to GLP-1 receptors (GLP-1Rs) on pancreatic beta cells. In addition, there is evidence that beta cell GLP-1Rs maintain sustained basal activity even in the absence of intestinal peptide, an observation that has raised the question whether these receptors have some degree of ligand-independent function. Here, we provide an alternative explanation for basal receptor activity based on our finding that biologically relevant amounts of fully processed GLP-1 are locally generated by insulinoma cell lines, as well as by alpha cells of isolated rat islets in primary culture. Presence of GLP-1 was established by immunocytochemistry, as well as by selective ELISAs and bioassays of cell supernatants. A GLP-1R antagonist significantly reduced insulin secretion/production in beta TC-6 insulinoma cells and isolated rat islets, suggesting a functionally important loop between locally produced GLP-1 and its cognate receptor. Treatment with this antagonist also inhibited the growth of beta TC-6 cells. These observations provide novel insight into the function of insulin-producing cell lines and native beta cells during in vitro culture, and support the idea that locally produced GLP-1 may play a role in intra-islet regulation.


Key words: Glucagon-like peptide • receptor • cell line • beta cell • insulin • growth • antagonist




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
R. D. Wideman, I. L. Y. Yu, T. D. Webber, C. B. Verchere, J. D. Johnson, A. T. Cheung, and T. J. Kieffer
Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1)
PNAS, September 5, 2006; 103(36): 13468 - 13473.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society